Skip to main content
Michael Ming, MD, Dermatology, Philadelphia, PA

MichaelEMingMD

Dermatology • Philadelphia, PA

Dermatopathology

Associate Professor, Dermatology, Perelman School of Medicine

Join to view full profile

Dr. Ming is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ming's full profile

Already have an account?

  • Office

    3400 Spruce Street
    2 Rhoads Pavilion
    Philadelphia, PA 19104
    Phone+1 215-662-2737
    Fax+1 215-349-8339

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Dermatopathology, 1997 - 1999
  • Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's Hosp
    Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1994 - 1997
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Internal Medicine, 1993 - 1994
  • Harvard Medical School
    Harvard Medical SchoolClass of 1993

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1997 - Present
  • PA State Medical License
    PA State Medical License 2000 - 2024
  • American Board of Dermatology Dermatology
  • American Board of Dermatology Dermatopathology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but with Positive Histologic Margins  
    Douglas Grossman, Vijay Balakrishnan, Laura K Ferris, Geoffrey Lim, Suephy C Chen, Meera Brahmbhatt, Susan M Swetter, Emily Y Chu, Nathaniel Fleming, Caroline C Kim, M..., JAMA
  • Timing of Onset of Adverse Cutaneous Reactions Associated with Programmed Cell Death Protein 1 Inhibitor Therapy  
    Tara C Mitchell, Michael E Ming, Leo L Wang, Suzanne McGettigan, Emily Y Chu, Lynn Schuchter, JAMA

Lectures

  • Practical Management of Atypical Melanocytic Lesions 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019

Press Mentions

  • Guidance on the Clinical Understanding and Use of Long‐Acting Injectable Antipsychotics in Schizophrenia: Hong Kong Consensus Statements
    Guidance on the Clinical Understanding and Use of Long‐Acting Injectable Antipsychotics in Schizophrenia: Hong Kong Consensus StatementsFebruary 8th, 2021
  • Cancer Patients May Experience Delayed Skin Effects of Anti-PD-1 Therapy
    Cancer Patients May Experience Delayed Skin Effects of Anti-PD-1 TherapyJuly 18th, 2018
  • Management Strategies of Academic Pigmented Lesion Clinic Directors in the United States
    Management Strategies of Academic Pigmented Lesion Clinic Directors in the United StatesJanuary 4th, 2018
  • Join now to see all

Professional Memberships

Dr. Michael Ming, Dr. Michael Ming, MD, Dr. M Ming, Dr. Michael E Ming